Medical materials

Publication
  • ACR •
  • 28 October, 2025 •
  • •

Economic Burden of Macrophage Activation Syndrome (MAS) in Patients with Still’s Disease (Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult-onset Still’s Disease (AOSD): Analysis of a US National Administrative Claims Database

Michael Marrone, Christopher McPherson, Abiola Oladapo

Available materials

Poster
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase Reduced Disease Burden in Patients With Uncontrolled Gout: Results From the Phase 3 DISSOLVE Trials

Puja Khanna, Amar Majjhoo, Rehan Azeem, Ben Peace, Bhavisha Desai, Vibeke Strand

Available materials

Oral Presentation
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Characterization of Infusion Reactions Within 1 Hour of Treatment With Nanoencapsulated Sirolimus Plus Pegadricase: Pooled Results From the Phase 3 DISSOLVE I and DISSOLVE II Trials

Herbert Baraf, Andrew Sulich, Guillermo Valenzuela, Rehan Azeem, Ben Peace, Bhavisha Desai, Herbert Baraf

Available materials

Poster
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) Demonstrates a Reduction in Gout Flares: Results From the Phase 3 DISSOLVE Studies

Angelo Gaffo, Herbert Baraf, Anand Patel, Tuhina Neogi, Rehan Azeem, Wesley DeHaan, Ben Peace, Hugues Santin-Janin, Bhavisha Desai, Naomi Schlesinger

Available materials

Oral Presentation
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Reduction in Tophi Observed in Patients With Uncontrolled Gout Treated With NASP: Results From Phase 3 DISSOLVE Studies

Herbert Baraf, Puja Khanna, Frédéric Lioté, Rehan Azeem, Wesley DeHaan, Ben Peace, Hugues Santin-Janin, Bhavisha Desai, Alan Kivitz

Available materials

Poster
Publication
  • ACR •
  • 28 October, 2025 •
  • •

A Real-World Survey on Physicians' Perspectives of Uncontrolled Gout and Gout Management Practices

John Botson, Menaka Bhor, Nathan Meyer, Emily Goddard, Molly Edwards, Victoria Barton, Jeff Peterson

Available materials

Poster
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Management of Uncontrolled Gout Among Rheumatologists: Findings from a Medical Chart Audit

Hyon Choi, Nana Kragh, Amod Athavale, Bhavisha Desai, Amal Gulaid, Abiola Oladapo, Brittany Smith, Kenneth Saag

Available materials

Poster
Publication
  • ACR •
  • 27 October, 2025 •
  • •

Emapalumab Treatment for Patients with Differing Presentations of Macrophage Activation Syndrome (MAS) Secondary to Still’s Disease: Results from a Pooled Analysis of Two Prospective Trials

Alexei A. Grom, Sebastian J. Vastert, Jordi Antón, Pierre Quartier, Bruno Fautrel, Paul Brogan, Edward M. Behrens, Melissa Elder, Francesca Minoia, Pavla Dolezalova, Robert Biesen, Masaki Shimizu, Uwe Ullmann, Adnan Mahmood, Andrew Danquah, Elena Burillo, Marco Petrimpol, Steve Mallett, Brian D. Jamieson, Fabrizio De Benedetti

Available materials

Oral Presentation
Publication
  • ACR •
  • 27 October, 2025 •
  • •

Nanoencapsulated Sirolimus plus Pegadricase (NASP) Demonstrates Long Term Efficacy and Safety in Patients with Uncontrolled Gout: Results from the 24-week Double-blind Extension of the Phase 3 DISSOLVE I Study

Alan Kivitz, Atul Singhal, Anand Patel, Rehan Azeem, Ben Peace, Bhavisha Desai, Herbert Baraf

Available materials

Poster
Publication
  • ACR •
  • 27 October, 2025 •
  • •

The Care Pathway and Treatment Patterns in Patients with Uncontrolled Gout: A Real-World Survey of Physicians in the United States

Gordon K. Lam, Menaka Bhor, James Hawthorne, Arinola Dada, Molly Edwards, Emily Goddard, John Albert

Available materials

Poster
Publication
  • ACR •
  • 27 October, 2025 •
  • •

Patient and Caregiver Perspectives on the Burden of Disease in Uncontrolled Gout: A Cross-Sectional Survey Study

Angelo Gaffo, Bhavisha Desai, Abiola Oladapo, Nana Kragh, Rebekah Zincavage, Brad Padilla, Naomi Schlesinger

Available materials

Poster
Publication
  • ACR •
  • 26 October, 2025 •
  • •

Baseline Pharmacodynamic Markers and Response to Emapalumab in Children and Adults with Macrophage Activation Syndrome (MAS) in Still’s Disease: Results from a Pooled Analysis of Two Prospective Trials

Edward M. Behrens, Sebastian J. Vastert, Jordi Antón, Pierre Quartier, Bruno Fautrel, Paul Brogan, Melissa Elder, Francesca Minoia, Pavla Dolezalova, Robert Biesen, Masaki Shimizu, Uwe Ullmann, Adnan Mahmood, Andrew Danquah, Elena Burillo, Marco Petrimpol, Steve Mallett, Brian D. Jamieson, Alexei A. Grom, Fabrizio De Benedetti

Available materials

Oral Presentation
Sign up for alerts